Créer un PDF Recommander Imprimer

ASCO 2009 Orlando

 

 

En direct d'Orlando

Results of the IFCT-0002 phase III study comparing a preoperative and a perioperative chemotherapy (CT) with two different CT regimens in resectable non-small cell lung cancer (NSCLC).
POSTER IFCT-0002 ON LINE

Evaluation of class III beta-tubulin (bTubIII) expression as a prognostic marker in patients with resectable non-small cell lung cancer (NSCLC) treated by perioperative chemotherapy (CT) in the phase III trial IFCT-0002.
POSTER Bio-IFCT-0002 ON LINE

Session: Lung Cancer - Local-Regional and Adjuvant Therapy
Type: Poster Discussion
Time: Saturday May 30, 8:00 AM to 12:00 PM
Location: Level 3, W315A

--------------------------------------------------------------------------------

Discussion: Saturday May 30, 12:00 PM to 1:00 PM
Location: Level 3, Chapin Theater W320

  • 1 poster (ERMETIC)

Biological and clinical prognostic factors in patients with advanced non-small-cell cancer (NSCLC) treated by erlotinib: Preliminary results of the ERMETIC cohort.
POSTER ERMETIC ON LINE

Session: Lung Cancer - Metastatic
Type: General Poster Session
Time: Saturday May 30, 2:00 PM to 6:00 PM
Location: Level 2, West Hall C

  • Dernière modification
    Mercredi, 03 Juin 2009
Mentions légales | Avertissement | © Copyright 2002 - 2014 IFCT Tous droits réservés